News and Commentary Archive

Explore recent scientific discoveries and news as well as CLBB events, commentary, and press.

Mission

The Center for Law, Brain & Behavior puts the most accurate and actionable neuroscience in the hands of judges, lawyers, policymakers and journalists—people who shape the standards and practices of our legal system and affect its impact on people’s lives. We work to make the legal system more effective and more just for all those affected by the law.

Supreme Court Takes On Racial Discrimination In Jury Selection

By Nina Totenberg | NPR | November 2, 2015

The U.S. Supreme Court wrestles Monday with a problem that has long plagued the criminal justice system: race discrimination in the selection of jurors. Continue reading »

“And if Your Friends Jumped Off a Bridge, Would you Do it Too?” – How Developmental Neuroscience can Inform Legal Regimes Governing Adolescence

By Michael N. Tennison and Amanda C. Pustilnik | Indiana Health Law Review

Introduction

On September 17, 2014, a teen boy riding in the front seat of an SUV on the highway at night had a brilliant idea: If he set the driver’s armpit hair on fire, it might impress the girls in the back. It did not turn out quite the way he planned. “Teen Setting Underarm Hair On Fire Causes Rollover Crash,” reported news outlets the next day. The SUV ran into a ditch, flipped over, and threw three of the five occupants—all teenagers, none of whom were wearing seat belts—out onto the highway. Miraculously, no one was killed.

This story is humorous and serious all at once. Humorous, because it embodies a head-shaking truth long acknowledged in our and other cultures about the crazy things kids do. Serious, because the thoughtless yet typical action of one boy could have seriously hurt or killed these four children and possibly other people on the highway that night. And it has a serious message: Teens are different from adults, on average, particularly in ways that relate to the overvaluation of present rewards and sensations, the undervaluation of negative risk, the tremendous salience of their desire for peer approval, and their tendency to act in even more risky and thoughtless ways when they are together in groups.

Continue reading the article here.

Genome-Wide Association Study Identifies SESTD1 as a Novel Risk Gene for Lithium-Responsive Bipolar Disorder

By J. Song, Sarah E. Bergen, Arianna Di Florio, R. Karlsson, Alexander Charney, Douglas M. Ruderfer, Eli A. Stahl, Members of the International Cohort Collection for Bipolar Disorder (ICCBD), Kimberly D. Chambert, Jennifer L. Moran, Katherine Gordon-Smith, Liz Forty, Elaine K. Green, Ian Jones, Lisa Jones, E. M. Scolnick, Pamela Sklar, Jordan W. Smoller, P. Lichtenstein, Christina Hultman, Nick Craddock, and Mikael Landén | Molecular Psychiatry | October 27, 2015

Abstract:

Lithium is the mainstay prophylactic treatment for bipolar disorder (BD), but treatment response varies considerably across individuals. Patients who respond well to lithium treatment might represent a relatively homogeneous subtype of this genetically and phenotypically diverse disorder. Here, we performed genome-wide association studies (GWAS) to identify (i) specific genetic variations influencing lithium response and (ii) genetic variants associated with risk for lithium-responsive BD. Patients with BD and controls were recruited from Sweden and the United Kingdom. GWAS were performed on 2698 patients with subjectively defined (self-reported) lithium response and 1176 patients with objectively defined (clinically documented) lithium response. We next conducted GWAS comparing lithium responders with healthy controls (1639 subjective responders and 8899 controls; 323 objective responders and 6684 controls). Meta-analyses of Swedish and UK results revealed no significant associations with lithium response within the bipolar subjects. However, when comparing lithium-responsive patients with controls, two imputed markers attained genome-wide significant associations, among which one was validated in confirmatory genotyping (rs116323614, P=2.74 × 10−8). It is an intronic single-nucleotide polymorphism (SNP) on chromosome 2q31.2 in the gene SEC14 and spectrin domains 1 (SESTD1), which encodes a protein involved in regulation of phospholipids. Phospholipids have been strongly implicated as lithium treatment targets. Furthermore, we estimated the proportion of variance for lithium-responsive BD explained by common variants (‘SNP heritability’) as 0.25 and 0.29 using two definitions of lithium response. Our results revealed a genetic variant in SESTD1 associated with risk for lithium-responsive BD, suggesting that the understanding of BD etiology could be furthered by focusing on this subtype of BD.

Read the full paper here.